James Samuel Shannon, Director at MannKind, holds 70.00K shares in Xilio Therapeutics (Ticker: XLO), holds 0.00 shares in Horizon Therapeutics (Ticker: HZNP), holds 12.74K shares in MannKind (Ticker: MNKD). Most recently, James Samuel Shannon Bought ― shares of Xilio Therapeutics on Jun 18, 2025 for an estimated value of 47.60K.
What is the percentage of profitable transactions made by James Samuel Shannon?
The percentage of profitable transactions made by James Samuel Shannon is ―.
What is the average return per transaction made by James Samuel Shannon?
The average return per transaction made by James Samuel Shannon is ―.
What stocks does James Samuel Shannon hold?
James Samuel Shannon holds: MNKD, HZNP, XLO, ECYT stocks.
What was James Samuel Shannon’s latest transaction?
James Samuel Shannon latest transaction was an Informative Buy of $47.60K.
What was James Samuel Shannon's most profitable transaction?
James Samuel Shannon’s most profitable transaction was an Informative Buy of XLO stock on June 18, 2025. The return on the trade was 9.30%.
What is James Samuel Shannon's role in MannKind?
James Samuel Shannon's role in MannKind is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.